Emory Healthcare - Advancing the Possibilities
Home   Medical Services   Patient Guide   Clinical Trials   Find a Physician   Health Library   Events   About Us   Contact Us
Emory Urology   
Urology
Patient/Visitor Guide
Urology FAQs
Oncology
Prostate Cancer Treatment
Continence And Female Urology
Men's Health
Stone Disease
Minimally Invasive Surgery
Urology Physicians
Contact Information
Research
Residency Program
Newsletters
Make a Gift
Events

Prostate Cancer Stages

Emory Prostate Center
404-686-BLUE

The Emory Clinic
1365 Clifton Road NE
Atlanta, GA 30322

After examination and biopsy, doctors will "stage" and "grade" prostate cancer with a system of letters and numbers.

Grade: Grade refers to the expected aggressiveness of the tumor based on the biopsy. The most common grading system is the Gleason system. Grades 1 and 2 are closer in appearance to normal glands, and are the slowest growing, better behaving tumors. Grades 4 and 5 have more variations in size of tumor cells and loss of glandular appearance, and are the more aggressive tumors. Usually there are 2 grades assigned to each biopsy, based on the most and the second-most extensive disease in the biopsy. Adding those 2 grades together gives a Gleason sum or score, such as 3+3 = 6/10, or 3+4 = 7/10. Gleason scores of 2-4 are considered well-differentiated (good), Gleason scores 5-7 are moderately-differentiated, and Gleason scores of 8-10 are poorly-differentiated (bad).

Stage: The clinical stage of a cancer is the extent of disease, whether it is localized, spread regionally, or spread more widely to lymph nodes or bones. A bone scan is performed when the PSA is quite high (over 20 or so), or the Gleason grade is 8-10. CT scan is often requested, but is of little value in predicting lymph node involvement unless the PSA is very high. A Prostascint scan, which is a nuclear scan of soft tissues, may be used to determine lymph node spread in patients with PSA over 30. Surgery gives the most complete staging, as the entire specimen is examined microscopically (pathologic stage), but many patients, such as those undergoing radiation, are managed on the basis of clinical staging.

A system of staging used by the National Cancer Institute and most doctors is called TNM (Tumor Nodes Metastases) Staging. Some patients may see or hear these types of symbols in their lab reports or discussions with their doctors.

Primary Tumor Staging: T

T1 Non-palpable microscopic disease
T1A Incidental; focal, involving <5% of prostate tissue following Transurethral Resection of Prostate (TURP), or low grade
T1B Incidental; diffuse, involving >5% of prostate tissue following TURP, or high grade
T1C Biopsy for elevated PSA
T2 Palpable disease confined to prostate
T2A On less than one-half of one side (lobe) of prostate
T2B On more than one-half of one side (lobe) of prostate, but not both sides
T2C On both sides of prostate
T3 Disease extends beyond prostate capsule or involves seminal vesicles
T4 Disease fixed or involves adjacent structures (bladder neck, external sphincter, rectum, levator muscles, pelvic sidewall)

Lymph Node Staging:N

NX Status of nodes unknown
N0 Nodes negative
N1-3 Nodes involved

Distant Metastatic Spread Staging: M

MX Status of distant disease spread unknown
M0 No evidence of metastases
M1b Bone metastases




 
Home | Medical Services | Patient Guide | Clinical Trials | Find a Physician | Health Library | Events | About Us | Contact Us
Medical Professionals | For Employees | Career Center | Contact an Emory Nurse | Personal Health Record | Site Map
© Emory Healthcare 2008 - All rights Reserved